glp-1 agonists: Agonists Resmetirom and GLP-1 agonists for

FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease

Recent advancementsincluding the approval of oral semaglutide (Rybelsus)have demonstrated the potential for effective oral peptide delivery, though such formulations still face significant pharmacokinetic and formulation-related challenges

In treating diabetes, when constipation is an issue, I already switch between Ozempic, the older GLP-1 medicines Victoza and Trulicity, and the newer Mounjaro

Genes affect how well semaglutide (Ozympic) and tirzepatide work

Recently, the Food and Drug Administration officially approved semaglutide for the treatment of metabolic dysfunction-associated steatohepatitis in adults with moderate-to-advanced fibrosis